AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Free Cash Flow

Annual FCF:

-$167.80M-$178.48M(-1671.49%)
December 31, 2024

Summary

  • As of today, AMLX annual free cash flow is -$167.80 million, with the most recent change of -$178.48 million (-1671.49%) on December 31, 2024.
  • During the last 3 years, AMLX annual free cash flow has fallen by -$92.65 million (-123.29%).
  • AMLX annual free cash flow is now -1671.49% below its all-time high of $10.68 million, reached on December 31, 2023.

Performance

AMLX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

Quarterly FCF:

-$30.39M-$5.13M(-20.29%)
September 30, 2025

Summary

  • As of today, AMLX quarterly free cash flow is -$30.39 million, with the most recent change of -$5.13 million (-20.29%) on September 30, 2025.
  • Over the past year, AMLX quarterly free cash flow has increased by +$47.36 million (+60.91%).
  • AMLX quarterly free cash flow is now -330.33% below its all-time high of $13.20 million, reached on December 31, 2023.

Performance

AMLX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

TTM FCF:

-$154.52M+$47.36M(+23.46%)
September 30, 2025

Summary

  • As of today, AMLX TTM free cash flow is -$154.52 million, with the most recent change of +$47.36 million (+23.46%) on September 30, 2025.
  • Over the past year, AMLX TTM free cash flow has dropped by -$22.74 million (-17.25%).
  • AMLX TTM free cash flow is now -1100.52% below its all-time high of $15.44 million, reached on March 31, 2024.

Performance

AMLX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

AMLX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-1671.5%+60.9%-17.3%
3Y3 Years-123.3%+30.2%-17.0%
5Y5 Years-1470.2%--

AMLX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1671.5%+8.0%-330.3%+60.9%-1100.5%+36.5%
5Y5-Year-1671.5%+8.0%-330.3%+60.9%-1100.5%+36.5%
All-TimeAll-Time-1671.5%+8.0%-330.3%+60.9%-1100.5%+36.5%

AMLX Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$30.39M(-20.3%)
-$154.52M(+23.5%)
Jun 2025
-
-$25.27M(+36.6%)
-$201.88M(+17.0%)
Mar 2025
-
-$39.84M(+32.5%)
-$243.29M(-19.3%)
Dec 2024
-$167.80M(-1671.5%)
-$59.03M(+24.1%)
-$204.01M(-54.8%)
Sep 2024
-
-$77.75M(-16.6%)
-$131.78M(-121.3%)
Jun 2024
-
-$66.67M(>-9900.0%)
-$59.56M(-485.6%)
Mar 2024
-
-$556.00K(-104.2%)
$15.44M(+44.6%)
Dec 2023
$10.68M
$13.20M(+338.8%)
$10.68M(+120.2%)
Sep 2023
-
-$5.53M(-166.3%)
-$52.83M(+41.8%)
Jun 2023
-
$8.33M(+256.5%)
-$90.84M(+38.1%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$5.32M(+89.4%)
-$146.74M(+19.5%)
Dec 2022
-$182.40M(-142.7%)
-$50.32M(-15.6%)
-$182.40M(-38.1%)
Sep 2022
-
-$43.54M(+8.5%)
-$132.08M(-49.2%)
Jun 2022
-
-$47.57M(-16.1%)
-$88.54M(-63.9%)
Mar 2022
-
-$40.98M(-214.1%)
-$54.02M(-110.2%)
Dec 2021
-$75.15M(-104.0%)
-
-
Jun 2021
-
-$13.05M(-3.1%)
-$25.70M(-103.1%)
Mar 2021
-
-$12.66M
-$12.66M
Dec 2020
-$36.85M(-244.8%)
-
-
Dec 2019
-$10.69M
-
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual free cash flow year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual free cash flow?

The current annual free cash flow of AMLX is -$167.80M

What is the all-time high annual free cash flow for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual free cash flow is $10.68M

What is Amylyx Pharmaceuticals, Inc. annual free cash flow year-on-year change?

Over the past year, AMLX annual free cash flow has changed by -$178.48M (-1671.49%)

What is Amylyx Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly free cash flow of AMLX is -$30.39M

What is the all-time high quarterly free cash flow for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly free cash flow is $13.20M

What is Amylyx Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?

Over the past year, AMLX quarterly free cash flow has changed by +$47.36M (+60.91%)

What is Amylyx Pharmaceuticals, Inc. TTM free cash flow?

The current TTM free cash flow of AMLX is -$154.52M

What is the all-time high TTM free cash flow for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high TTM free cash flow is $15.44M

What is Amylyx Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

Over the past year, AMLX TTM free cash flow has changed by -$22.74M (-17.25%)
On this page